tiprankstipranks
Trending News
More News >
Northwest Biotherapeutics (NWBO)
:NWBO
US Market

Northwest Biotherapeutics (NWBO) Income Statement

Compare
530 Followers

Northwest Biotherapeutics Income Statement

Last quarter (Q3 2025), Northwest Biotherapeutics's total revenue was $200.00K, a decrease of -13.42% from the same quarter last year. In Q3, Northwest Biotherapeutics's net income was $-27.18M. See Northwest Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.38M$ 1.93M$ 1.68M$ 1.00M$ 1.29M
Gross Profit
$ 1.38M$ -25.80M$ 135.00K$ -19.30M$ -32.35M
Operating Expenses
$ 67.89M$ 57.44M$ 68.86M$ 53.71M$ 54.26M
Depreciation and Amortization
$ 2.04M$ 1.73M$ 1.55M$ 586.00K$ 425.00K
EBITDA
$ -73.64M$ -55.34M$ -97.42M$ 184.72M$ -520.85M
Operating Income
$ -66.51M$ -55.51M$ -67.18M$ -52.70M$ -86.61M
Other Income/Expenses
$ -17.27M$ -7.09M$ -37.85M$ 231.83M$ -443.22M
Pretax Income
$ -83.78M$ -62.60M$ -105.03M$ 179.13M$ -529.82M
Net Income
$ -83.78M$ -62.60M$ -105.03M$ 179.13M$ -529.82M
Per Share Metrics
Basic EPS
$ -0.07$ -0.06$ -0.10$ 0.21$ -0.73
Diluted EPS
$ -0.07$ -0.06$ -0.10$ -0.06$ -0.73
Weighted Average Shares Outstanding
1.24B 1.12B 1.02B 873.52M 725.13M
Weighted Average Shares Outstanding (Diluted)
1.24B 1.12B 1.02B 1.01B 725.13M
Currency in USD

Northwest Biotherapeutics Earnings and Revenue History